IP Library › Assignment 055694/0324
Patent Assignment
Reel/Frame 055694/0324

Assignment of Assignor's Interest

Recorded: 2021-03-23 Pages: 63
Assignor
SAMUMED, LLC
Executed: 2021-03-05
Assignee
BIOSPLICE THERAPEUTICS, INC.
9360 TOWNE CENTRE DRIVE, SAN DIEGO, CALIFORNIA, 92121
Covered Properties (77)
Methods for Identifying Compounds that Modulate WNT Signaling in Cancer Cells
Application: 61/051,322 →
Methods for Identifying Compounds that Affect Expression of Cancer-Related Protein Isoforms
Application: 61/051,324 →
Methods for Identifying Compounds that Modulate WNT Signaling in Cancer Cells
Application: 61/083,870 →
Wnt Inhibitors and Methods of Use
Application: 61/232,603 →
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Application: 61/288,544 →
Indazoles and Therapeutic Uses Thereof
Application: 61/305,459 →
Beta- and Gamma-Diketones and Gamma-Hydroxyketones as Wnt/Beta-Catenin Signaling Pathway Activators
Application: 61/374,687 →
Beta- and Gamma-Diketones and Gamma-Hydroxyketones as Wnt/Beta-Catenin Signaling Pathway Activators
Application: 61/427,974 →
Indazole-3-Carboxamides and Their Use as Wnt/B-Catenin Signaling Pathway Inhibitors
Application: 61/534,601 →
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Application: 61/620,107 →
Indazole-3-Carboxamides and Their Use as Wnt/B-Catenin Signaling Pathway Inhibitors
Application: 61/624,646 →
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Application: 61/642,915 →
3-(Benzoimidazol-2-Yl)-Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Application: 61/750,221 →
Gamma-Diketones as Wnt/Beta -Catenin Signaling Pathway Activators
Application: 61/768,033 →
5-Substituted Indazole-3-Carboxamides and Preparation and Use Thereof
Application: 61/968,350 →
Gamma-Diketones for Treatment and Prevention of Aging Skin and Wrinkles
Application: 62/039,786 →
2-(1H-Indazol-3-Yl)-1H-Imidazo[4,5-C]Pyridine and Therapeutic Uses Thereof
Application: 62/047,324 →
3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
Application: 62/047,371 →
3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
Application: 62/047,395 →
2-(1H-Indazol-3-Yl)-3H-Imidazo[4,5-B]Pyridine and Therapeutic Uses Thereof
Application: 62/047,401 →
3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridine and Therapeutic Uses Thereof
Application: 62/047,406 →
3-(3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
Application: 62/047,438 →
3-(1H-Benzo[D]Imidazol-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
Application: 62/047,509 →
3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridine and Therapeutic Uses Thereof
Application: 62/047,575 →
3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridine and Therapeutic Uses Thereof
Application: 62/051,567 →
3-(1H-Pyrrolo[2,3-B]Pyridin-2-Yl)-1H-Indazoles and Therapeutic Uses Thereof
Application: 62/200,187 →
3-(1H-Pyrrolo[3,2-C]Pyridin-2-Yl)-1H-Indazoles and Therapeutic Uses Thereof
Application: 62/200,190 →
3-(1H-Indol-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
Application: 62/200,195 →
3-(1H-Pyrrolo[3,2-C]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
Application: 62/200,201 →
3-(1H-Indol-2-Yl)-1H-Indazoles and Therapeutic Uses Thereof
Application: 62/200,226 →
3-(1H-Pyrrolo[2,3-C]Pyridin-2-Yl)-1H-Indazoles and Therapeutic Uses Thereof
Application: 62/200,229 →
3-(1H-Pyrrolo[2,3-C]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
Application: 62/200,259 →
3-(1H-Pyrrolo[2,3-B]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
Application: 62/200,275 →
3-(1H-Pyrrolo[2,3-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Application: 62/200,279 →
3-(1H-Pyrrolo[2,3-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Application: 62/200,301 →
3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
Application: 62/200,329 →
3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
Application: 62/200,377 →
3-(1H-Pyrrolo[3,2-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Application: 62/200,392 →
3-(1H-Pyrrolo[2,3-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridines and Therapeutic Uses Thereof
Application: 62/200,412 →
3-(3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
Application: 62/200,423 →
3-(1H-Indol-2-Yl)-1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Application: 62/200,426 →
3-(1H-Pyrrolo[3,2-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridines and Therapeutic Uses Thereof
Application: 62/200,433 →
3-(1H-Pyrrolo[2,3-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridines and Therapeutic Uses Thereof
Application: 62/200,450 →
3-(1H-Indol-2-Yl)-1H-Pyrazolo[3,4-C]Pyridines and Therapeutic Uses Thereof
Application: 62/200,468 →
3-(1H-Benzo[D]Imidazol-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
Application: 62/200,492 →
Treatment of Osteoarthritis
Application: 62/252,332 →
Treatment of Osteoarthritis
Application: 62/303,168 →
3-(1H-Benzo[D]Imidazol-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
Application: 62/313,506 →
3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
Application: 62/313,535 →
3-(3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
Application: 62/313,568 →
3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
Application: 62/313,576 →
Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Application: 62/328,210 →
Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Application: 62/328,255 →
Process for Preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide
Application: 62/344,170 →
3-(1H-Indol-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
Application: 62/353,947 →
3-(1H-Pyrrolo[3,2-C]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
Application: 62/354,000 →
3-(1H-Pyrrolo[2,3-C]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
Application: 62/354,014 →
3-(1H-Pyrrolo[2,3-B]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
Application: 62/354,021 →
3-(1H-Indol-2-Yl)-1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Application: 62/356,068 →
3-(1H-Pyrrolo[3,2-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Application: 62/356,103 →
3-(1H-Pyrrolo[2,3-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Application: 62/356,108 →
3-(1H-Pyrrolo[2,3-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Application: 62/356,133 →
Methods of Using Indazole-3-Carboxamides and Their Use as Wnt/B-Catenin Signaling Pathway Inhibitors
Application: 62/411,478 →
Process for Preparing N-(5-(3-(7-(3-Fluorophenyl)-3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Indazol-5-Yl)Pyridin-3-Yl)-3-Methylbutanamide
Application: 62/418,657 →
Single-Dose, Ready-to-Use Injectable Formulations
Application: 62/418,688 →
6-(5-Membered Heteroaryl)Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Application: 62/574,568 →
6-(6-Membered Heteroaryl & Aryl)Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Application: 62/577,818 →
6-(5-Membered Heteroaryl)Isoquinolin-3-Yl-(5-Membered Heteroaryl) Carboxamides and Preparation and Use Thereof
Application: 62/578,370 →
6-(5-Membered Heteroaryl)Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Application: 62/578,691 →
Diazanaphthalen-3-Yl Carboxamides and Preparation and Use Thereof
Application: 62/579,883 →
5-Heteroaryl Substituted Indazole-3-Carboxamides and Preparation and Use Thereof
Application: 62/634,656 →
Indazole Containing Macrocycles and Therapeutic Uses Thereof
Application: 62/685,764 →
Methods of Treating Cancer Using a Clk Inhibitor
Application: 62/690,146 →
Pyrazole Derivatives as Modulators of the Wnt B Catenin Signaling Pathway
Application: 62/793,428 →
Methods of Treating Cartilage Disorders Through Inhibition of Clk and Dyrk
Application: 62/793,855 →
Pyrazole Derivatives as Modulators of the Wnt/Beta-Catenin Signaling Pathway
Application: 62/831,478 →
Methods of Treating Cancer Using a Clk Inhibitor
Application: 62/846,335 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 11, 2010
From: HOOD, JOHN; KC, SUNIL KUMAR
To: WINTHERIX, LLC
Reel/Frame 023757/0444 →
Assignment of Assignor's Interest Jan 11, 2010
From: HOOD, JOHN; KC, SUNIL KUMAR; WALLACE, DAVID MARK
To: WINTHERIX, LLC
Reel/Frame 023757/0478 →
Assignment of Assignor's Interest Apr 20, 2010
From: HOOD, JOHN; WALLACE, DAVID MARK; KC, SUNIL KUMAR
To: WINTHERIX, LLC
Reel/Frame 024256/0773 →
Assignment of Assignor's Interest Jun 11, 2010
From: WINTHERIX, LLC
To: EPITHERIX, LLC
Reel/Frame 024520/0197 →
Assignment of Assignor's Interest Aug 20, 2010
From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; HOOD, JOHN; BARROGA, CHARLENE F.
To: WINTHERIX, LLC
Reel/Frame 024863/0006 →
Assignment of Assignor's Interest Apr 19, 2011
From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; HOOD, JOHN; BARROGA, CHARLENE F.
To: WINTHERIX, LLC
Reel/Frame 026148/0358 →
Assignment of Assignor's Interest Oct 10, 2011
From: HOOD, JOHN; KC, SUNIL KUMAR
To: EPITHERIX, LLC
Reel/Frame 027036/0216 →
Assignment of Assignor's Interest Jun 26, 2012
From: EPITHERIX, LLC
To: SAMUMED, LLC
Reel/Frame 028442/0355 →
Assignment of Assignor's Interest Jul 6, 2012
From: HOOD, JOHN; KC, SUNIL KUMAR
To: SAMUMED, LLC
Reel/Frame 028497/0960 →
Assignment of Assignor's Interest Jul 6, 2012
From: HOOD, JOHN; WALLACE, DAVID MARK; KC, SUNIL KUMAR
To: SAMUMED, LLC
Reel/Frame 028497/0879 →
Assignment of Assignor's Interest Jul 6, 2012
From: HOOD, JOHN; KC, SUNIL KUMAR; WALLACE, DAVID MARK
To: SAMUMED, LLC
Reel/Frame 028498/0046 →
Assignment of Assignor's Interest Feb 6, 2013
From: KC, SUNIL KUMAR; HOOD, JOHN
To: SAMUMED, LLC
Reel/Frame 029766/0258 →
Assignment of Assignor's Interest Oct 15, 2013
From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; HOOD, JOHN; BARROGA, CHARLENE F.
To: SAMUMED, LLC
Reel/Frame 031407/0226 →
Assignment of Assignor's Interest Jul 15, 2014
From: HOOD, JOHN; KC, SUNIL KUMAR; WALLACE, DAVID MARK; MITTAPALLI, GOPI KUMAR
To: SAMUMED, LLC
Reel/Frame 033311/0958 →
Assignment of Assignor's Interest Sep 10, 2014
From: HOOD, JOHN; KC, SUNIL KUMAR; KIBAR, OSMAN; BARROGA, CHARLENE F.
To: SAMUMED, LLC
Reel/Frame 033710/0390 →
Assignment of Assignor's Interest Sep 25, 2014
From: HOOD, JOHN; KC, SUNIL KUMAR; WALLACE, DAVID MARK
To: SAMUMED, LLC
Reel/Frame 033818/0676 →
Assignment of Assignor's Interest Sep 25, 2014
From: HOOD, JOHN; KC, SUNIL KUMAR; WALLACE, DAVID MARK
To: SAMUMED, LLC
Reel/Frame 033818/0546 →
Assignment of Assignor's Interest Sep 25, 2014
From: HOOD, JOHN; KC, SUNIL KUMAR; WALLACE, DAVID MARK
To: SAMUMED, LLC
Reel/Frame 033818/0447 →
Assignment of Assignor's Interest Sep 26, 2014
From: HOOD, JOHN; KC, SUNIL KUMAR; WALLACE, DAVID MARK
To: SAMUMED, LLC
Reel/Frame 033830/0088 →
Assignment of Assignor's Interest Sep 26, 2014
From: HOOD, JOHN; KC, SUNIL KUMAR; WALLACE, DAVID MARK
To: SAMUMED, LLC
Reel/Frame 033829/0382 →
Assignment of Assignor's Interest Sep 26, 2014
From: HOOD, JOHN; KC, SUNIL KUMAR; WALLACE, DAVID MARK
To: SAMUMED, LLC
Reel/Frame 033829/0272 →
Assignment of Assignor's Interest Sep 29, 2014
From: HOOD, JOHN; KC, SUNIL KUMAR; WALLACE, DAVID MARK
To: SAMUMED, LLC
Reel/Frame 033837/0456 →
Assignment of Assignor's Interest Sep 29, 2014
From: HOOD, JOHN; KC, SUNIL KUMAR; WALLACE, DAVID MARK
To: SAMUMED, LLC
Reel/Frame 033837/0388 →
Assignment of Assignor's Interest Nov 11, 2014
From: HOOD, JOHN; KC, SUNIL KUMAR; WALLACE, DAVID MARK
To: SAMUMED, LLC
Reel/Frame 034142/0508 →
Assignment of Assignor's Interest Aug 24, 2015
From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; CAO, JIANGUO; HOOD, JOHN
To: SAMUMED, LLC
Reel/Frame 036403/0908 →